SBI JI Innovation Fund is a biopharma focused venture capital firm. SBI JI Innovation Fund was formed as a partnership between SBI Holdings of Japan and Vertex.
Akerstein Towers B, 3rd Floor
11 HaMenofim St.
|2020-03-11||BioSight||Series C||$19M||Arkin Holdings, and Israel Biotech Fund|
|2019-10-02||Adicet Bio||Series B||$80M||aMoon Partners, Consensus Business Group, DSC Investment, Handok, Johnson & Johnson Innovation, KB Investment, Novartis Venture Funds, OCI Enterprises, OrbiMed Advisors, Pontifax, Regeneron Pharmaceuticals, and Samsung Ventures|
|2019-05-28||Ayala Pharmaceuticals||Series B||$30M||aMoon Partners, Harel Insurance Investments & Financial Services, Israel Biotech Fund, and Novartis|
|2019-02-20||BiomX||Series B||$32M||8VC, Chong Kun Dang Pharmaceutical, Consensus Business Group, Handok, Johnson & Johnson Innovation, KB Investment, Mirae Asset Capital, Mirae Asset Venture Investment, OrbiMed Advisors, RM Global Partners, Seventure Partners, Takeda Ventures, and Undisclosed Investors|
|2019-01-08||Biond Biologics||Series B||$17M||Celgene, Harel Insurance Investments & Financial Services, Israel Biotech Fund, and Undisclosed Investors|